These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27232633)

  • 1. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
    Ritorto MS; Rhode H; Vogel A; Borlak J
    Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
    Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
    Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
    Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
    J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
    Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
    He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes.
    Li Z; Zheng W; Li H; Li C; Gong Z
    PLoS One; 2015; 10(7):e0132319. PubMed ID: 26147004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GPI-PLD inhibits the growth of hepatoma cells by down-regulation of PI3K-Akt signaling pathway].
    Yang Z; Tan C; Yang Z; Huang H; Tang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):873-8. PubMed ID: 25269495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STK33 promotes hepatocellular carcinoma through binding to c-Myc.
    Yang T; Song B; Zhang J; Yang GS; Zhang H; Yu WF; Wu MC; Lu JH; Shen F
    Gut; 2016 Jan; 65(1):124-33. PubMed ID: 25398772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
    Ladu S; Calvisi DF; Conner EA; Farina M; Factor VM; Thorgeirsson SS
    Gastroenterology; 2008 Oct; 135(4):1322-32. PubMed ID: 18722373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSA attenuates the progression of c-Myc-driven hepatocarcinogenesis by pAKT-ADH4 pathway.
    Liu Y; Yu J; An X; Rao H; Qiu Z; Ke J; Wu L; Zhu Z; Deng H; Wu F; Zhang Z; Li S
    BMC Cancer; 2024 Aug; 24(1):1049. PubMed ID: 39187747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
    Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
    Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma.
    Ge Z; Zhang B; Bu X; Wang Y; Xiang L; Tan J
    Tumour Biol; 2014 Dec; 35(12):12441-7. PubMed ID: 25195135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.